Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.
Opioid Use Disorder and COVID-19: Biological Plausibility for Worsened Outcomes.
复制标题
DOI:
10.1080/10826084.2020.1791184
复制
发表时间:
2020
影响因子:
2
通讯作者:
Manini AF
中科院分区:
文献类型:
--
作者:
Schimmel J;Manini AF
Alarms have been raised that COVID-19 may disproportionately affect certain populations with substance use disorders, particularly Opioid Use Disorder (OUD), however warnings have largely focused on social risks such as reduced availability of services. This commentary highlights three plausible biological mechanisms for potentially worsened outcomes in patients with OUD who contract COVID-19. Opioid-related respiratory depression may amplify risks of hypoxemia from COVID-19 viral pneumonia. Complex opioid immune modulation may impact host response to COVID-19, though the effect direction and clinical significance are unclear. Drug-drug interactions may affect individuals with OUD who are co-administered medications for OUD and medications for COVID-19, particularly due to cardiac adverse effects. There are plausible biological mechanisms for potentially worsened outcomes in patients with OUD who contract COVID-19; these mechanisms require further study, and should be considered in individuals with OUD.
登录
查看更多内容
影响因子:
6.2
作者:
Roy, Sabita;Ninkovic, Jana;Banerjee, Santanu;Charboneau, Richard Gene;Das, Subhas;Dutta, Raini;Kirchner, Varvara A.;Koodie, Lisa;Ma, Jing;Meng, Jingjing;Barke, Roderick A.
通讯作者:
Barke, Roderick A.
影响因子:
4.2
作者:
Vallejo, Ricardo;de Leon-Casasola, Oscar;Benyamin, Ramsun
通讯作者:
Benyamin, Ramsun
DOI:
10.1001/jama.2020.6775
发表时间:
2020-01-01
期刊:
JAMA, Journal of the American Medical Association
影响因子:
--
作者:
Richardson, Safiya;Hirsch, Jamie S.;,
通讯作者:
,
影响因子:
8.9
作者:
Giudicessi, John R.;Noseworthy, Peter A.;Ackerman, Michael J.
通讯作者:
Ackerman, Michael J.
影响因子:
5.4
作者:
Zhao, Jincun;Zhao, Jingxian;Perlman, Stanley
通讯作者:
Perlman, Stanley